Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gina Barzen

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Cardiology|December 4, 2023
Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry diseaseIsabel Mattig, Tilman Steudel, Gina Barzen, et al.
Studies in Health Technology and Informatics|April 9, 2025
Implementing PyautoGUI for Enhanced Heart Team Protocol Creation: Improving Efficiency in Cardiovascular Patient ManagementRoberto Fernandes Branco, Diego Fernandes Branco, Isabel Mattig, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|April 9, 2026
Cardiac Multifrequency Time-harmonic Elastography: In Silico Validation and In Vivo ApplicationStefan Klemmer Chandía, Brunhilde Wellge, Gina Barzen, et al.
BMJ Open|March 23, 2025
Protocol of the follow-up of patients with transthyretin amyloid cardiomyopathy by multimodality imaging (FAITH) study: a prospective observational study in patients with ATTR-CM undergoing treatment with tafamidisJan Gröschel, Gina Barzen, Jasmin Zernikow, et al.
European Heart Journal Open|June 12, 2024
Diagnostic value of left ventricular layer strain and specific regional strain patterns in cardiac amyloidosis and Fabry diseaseTilman Steudel, Gina Barzen, David Frumkin, et al.
The Lancet Regional Health. Europe|July 17, 2025
Rurality, travel distance, and effectiveness of remote patient management in patients with heart failure in the TIM-HF2 trial in Germany: a pre-specified analysis of an open-label, randomised controlled trialFabian Kerwagen, Stefan Störk, Kerstin Koehler, et al.
Scientific Reports|May 2, 2024
Neurological affection and serum neurofilament light chain in wild type transthyretin amyloidosisHelena F Pernice, Adrian L Knorz, Paul J Wetzel, et al.
European Journal of Preventive Cardiology|April 22, 2026
Screening for amyloidosis before aortic valve elective replacement: results from the SAVER studyIsabel Mattig, Katrin Wrede-Wihl, Selin Sökmen, et al.
Scientific Reports|April 24, 2026
Transferability of a US claims-based machine learning model for ATTRwt-CM identification: a retrospective evaluation in a German settingHarisa Muratovic-Colic, Miriam R Hübner, Jan-Filip Rehburg, et al.
Plos One|June 2, 2026
On the crossroads of interdisciplinary medicine in amyloidosis - study protocol for a single-center interdisciplinary registry studyHelena Pernice, Gina Barzen, Jakub Piwowarski, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Cardiology|December 4, 2023
Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry diseaseIsabel Mattig, Tilman Steudel, Gina Barzen, et al.
Studies in Health Technology and Informatics|April 9, 2025
Implementing PyautoGUI for Enhanced Heart Team Protocol Creation: Improving Efficiency in Cardiovascular Patient ManagementRoberto Fernandes Branco, Diego Fernandes Branco, Isabel Mattig, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|April 9, 2026
Cardiac Multifrequency Time-harmonic Elastography: In Silico Validation and In Vivo ApplicationStefan Klemmer Chandía, Brunhilde Wellge, Gina Barzen, et al.
BMJ Open|March 23, 2025
Protocol of the follow-up of patients with transthyretin amyloid cardiomyopathy by multimodality imaging (FAITH) study: a prospective observational study in patients with ATTR-CM undergoing treatment with tafamidisJan Gröschel, Gina Barzen, Jasmin Zernikow, et al.
European Heart Journal Open|June 12, 2024
Diagnostic value of left ventricular layer strain and specific regional strain patterns in cardiac amyloidosis and Fabry diseaseTilman Steudel, Gina Barzen, David Frumkin, et al.
The Lancet Regional Health. Europe|July 17, 2025
Rurality, travel distance, and effectiveness of remote patient management in patients with heart failure in the TIM-HF2 trial in Germany: a pre-specified analysis of an open-label, randomised controlled trialFabian Kerwagen, Stefan Störk, Kerstin Koehler, et al.
Scientific Reports|May 2, 2024
Neurological affection and serum neurofilament light chain in wild type transthyretin amyloidosisHelena F Pernice, Adrian L Knorz, Paul J Wetzel, et al.
European Journal of Preventive Cardiology|April 22, 2026
Screening for amyloidosis before aortic valve elective replacement: results from the SAVER studyIsabel Mattig, Katrin Wrede-Wihl, Selin Sökmen, et al.
Scientific Reports|April 24, 2026
Transferability of a US claims-based machine learning model for ATTRwt-CM identification: a retrospective evaluation in a German settingHarisa Muratovic-Colic, Miriam R Hübner, Jan-Filip Rehburg, et al.
Plos One|June 2, 2026
On the crossroads of interdisciplinary medicine in amyloidosis - study protocol for a single-center interdisciplinary registry studyHelena Pernice, Gina Barzen, Jakub Piwowarski, et al.
Pageof 3